_48A0899.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
_48A0897.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
_48A0896.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
_48A0894.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
_48A0895.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
_48A0892.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
_48A0890.jpg
HIVR4P, the 5th HIV Research for Prevention Conference. Lima, Peru. OCT 07, 2024 SAT 22 Understanding and managing intellectual property for HIV vaccine research and development. Petro Terblanche (Afrigen Biologics and Vaccines, South Africa,) and Jerome Kim (International Vaccine Institute (IVI), South Korea)
left
right
Load more
© International AIDS Society, 2026
Powered by Pics.io Digital Assets Management Solution